Assessment of Ah receptor transcriptional activity mediated by halogenated dibenzo-p-dioxins and dibenzofurans (PXDD/Fs) in human and mouse cell systems

References

• Kociba, R.J.; Keyes, D.G.; Beyer, J.E.; Carreon, R.M.; Wade, C.E.; Dittenber, D.A.; Kalnins, R.P.; Frauson, L.E.; Park, C.N.; Barnard, S.D.; Hummel, R.A.; Humiston, C.G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachloro-p-dioxin in rats. Toxicol. Appl. Pharmacol. 1978, 46, 279–303.
   PubMed Web of Science ®Google Scholar
• Mimura, J.; Fujii-Kuriyama, Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta 2003, 1619, 263–268.
   PubMed Web of Science ®Google Scholar
• Boffetta, P.; Mundt, K.A.; Adami, H.O.; Cole, P.; Mandel, J.S. TCDD and cancer: A critical review of epidemiologic studies. Crit. Rev. Toxicol. 2011, 41, 622–636.
   PubMed Web of Science ®Google Scholar
• Whitlock, J. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu. Rev. Pharmacol. Toxicol. 1990, 30, 251–277.
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 1997. ISBN 92 832 1269 X.
   Google Scholar
• 2016 Report on Carcinogens, National Toxicology Program, US Department of Health and Human Services, http://ntp.niehs.nih.gov/go/roc14.
   Google Scholar
• Van den Berg, M.; Denison, M.S.; Birnbaum, L.S.; DeVito, M.J.; Fiedler, H.; Falandysz, J.; Rose, M.; Schrenk, D.; Safe, S.; Tohyama, C.; Tritscher, A.; Tysklind, M.; Peterson, R.E. Polybrominated dibenzo-p-dioxins, dibenzofurans, and biphenyls: Inclusion in the toxicity equivalency factor concept for dioxin-like compounds. Toxicol. Sci. 2013, 133, 197–208.
   PubMed Web of Science ®Google Scholar
• Mennear, J.H.; Lee, C.C. Polybrominated dibenzo-p-dioxins and dibenzofurans: Literature review and health assessment. Environ. Health Perspect. Suppl. 1994, 102, 265–274.
   PubMed Web of Science ®Google Scholar
• Behnisch, P.A.; Hosoe, K.; Sakai, S. Brominated dioxin-like compounds: In vitro assessment in comparison to classical dioxin-like compounds and other polyaromatic compound. Environ. Int. 2003, 29, 861–877.
   PubMed Web of Science ®Google Scholar
• Olsman, H.; Engwall, M.; Kammann, U.; Klempt, M.; Otte, J.; Van Bavel, B.; Hollert, H. Relative differences in aryl hydrocarbon receptor-mediated response for 18 polybrominated and mixed halogenated dibenzo-p-dioxins and –furans in cell lines from four different species. Environ. Toxicol. Chem. 2007, 26, 2448–2454.
   PubMed Web of Science ®Google Scholar
• Mason, G.; Zacharewski, T.; Denomme, M.A.; Safe, L.; Safe, S. Polybrominated dibenzo-p-dioxins and related compounds: Quantitative in vivo and in vitro structure-activity relationships. Toxicology 1987, 44, 245–255.
   PubMed Web of Science ®Google Scholar
• Mennear, J.H.; Lee, C.C. Polybrominated dibenzo-p-dioxins and dibenzofurans: Literature review and health assessment. Environ. Health Perspect. Suppl. 1994, 102, 265–274.
   PubMed Web of Science ®Google Scholar
• Birnbaum, L.S.; Staskal, D.F.; Diliberto, J.J. Health effects of polybrominated dibenzo-p-dioxins (PBDDs) and dibenzofurans (PBDFs). Environ. Int. 2003, 29, 855–860.
   PubMed Web of Science ®Google Scholar
• D'Silva, K.; Fernandes, A.; Rose, M. Brominated organic micropollutants-Igniting the flame retardant issue. Crit. Rev. Environ. Sci. Technol. 2004, 34, 141–207.
   Web of Science ®Google Scholar
• Van den Berg, M.; Birnbaum, L.S.; Denison, M.; De Vito, M.; Farland, W.; Feeley, M.; Fiedler, H.; Hakansson, H.; Hanberg, A.; Haws, L.; Rose, M.; Safe, S.; Schrenk, D.; Tohyama, C.; Tritscher, A.; Tuomisto, J.; Tysklind, M.; Walker, N.; Peterson, R.E. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 2006, 93, 223–241.
   PubMed Web of Science ®Google Scholar
• Chatkittikunwong, W.; Creaser, C.S. Bromo-, bromochloro-, and chloro-dibenzo-p-dioxins and dibenzofurans in incinerator flyash. Chemosphere 1994, 29, 559–566.
   Web of Science ®Google Scholar
• Organtini, K.L.; Myers, A.L.; Jobst, K.J.; Cochran, J.; Ross, B.; McCarry, B.; Reiner, E.J.; Dorman, F.L. Comprehensive characterization of the halogenated dibenzo-p-dioxin and dibenzofuran contents of residential fire debris using comprehensive two-dimensional gas chromatography coupled to time of flight mass spectrometry. J. Chromatogr. A. 2014, 146, 138–146.
   Web of Science ®Google Scholar
• Zeig-Owens, R.; Webber, M.P.; Hall, C.B.; Schwartz, T.; Jaber, N.; Weakley, J.; Rohan, T.E.; Cohen, H.W.; Derman, O.; Aldrich, T.K.; Kelly, K.; Prezant, D.J. Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: An observational cohort study. Lancet 2011, 378, 898–905.
   PubMed Web of Science ®Google Scholar
• Li, J.; Cone, J.E.; Kahn, A.R.; Brackbill, R.M.; Farfel, M.R.; Greene, C.M.; Hadler, J.L.; Stayner, L.T.; Stellman, S.D. Association between World Trade Center exposure and excess cancer risk. J. Am. Med. Assoc. 2012, 308, 2479–2488.
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency Risk Assessment Forum. Supplementary guidance for conducting health risk assessment of chemical mixtures. August 2000.
   Google Scholar
• Flaveny, C.A.; Perdew, G.H. Transgenic humanized AHR mouse reveals differences between human and mouse AHR ligand selectivity. Mol. Cell Pharmacol. 2009, 1, 119–123.
   PubMedGoogle Scholar
• Samara, F.; Gullett, B.K.; Harrison, R.O.; Chu, A.; Clark, G.C. Determination of relative assay response factors for toxic chlorinated and brominated dioxins/furans using an enzyme immunoassay (EIA) and a chemically-activated luciferase gene expression cell bioassay (CALUX). Environ. Int. 2009, 35, 588–593.
   PubMed Web of Science ®Google Scholar
• Behnisch, P.; Hosoe, K.; Shiozaki, K.; Sakai, S. Determination of the dioxin-like activity of several polyhalogenated (X = Br, Cl) aromatic hydrocarbons (PHAHs) by the micro-erod bioassay. Organohalogen Compd. 2000, 45, 220–223.
   Google Scholar
• Behnisch, P.; Hosoe, K.; Sakai, S. Brominated dioxin-like compounds: In vitro assessment in comparison to classical dioxin-like compounds and other polyaromatic compounds. Environ. Int. 2003, 29, 861–877.
   PubMed Web of Science ®Google Scholar
• Mason, G.; Zacharewski, T.; Denomme, M.A.; Safe, L.; Safe, S. Polybrominated dibenzo-p-dioxins and related compounds: Quantitative in vivo and in vitro structure-activity relationships. Toxicology 1987, 44, 245–255.
   PubMed Web of Science ®Google Scholar
• Mason, G.; Denomme, M.A.; Safe, L.; Safe, S. Polybrominated and chlorinated dibenzo-p-dioxins: Synthesis biologic and toxic effects and structure-activity relationships. Chemosphere 1987, 16, 1729–1731.
   Web of Science ®Google Scholar
• Safe, S.; Davis, D.; Romkes, M.; Yao, C.; Keyes, B.; Piskorska-Pliszczynska, J.; Farrell, K.; Mason, G.; Denomme, M.A.; Safe, L.; Zmudzka, B.; Holcomb, M. Development and validation of in vitro bioassays for 2,3,7,8-TCDD equivalents. Chemosphere 1989, 19, 853–860.
   Web of Science ®Google Scholar
• Long, W.P.; Pray-Grant, M.; Tsai, J.C.; Perdew, G.H. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol. Pharmacol. 1998, 53, 691–700
   PubMed Web of Science ®Google Scholar
• Smith, K.J.; Murray, I.A.; Tanos, R.; Tellew, J.; Boitano, A.E.; Bisson, W.H.; Kolluri, S.K.; Cooke, M.P.; Perdew, G.H. Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. J. Pharmacol. Exp. Ther. 2011, 338, 318–327.
   PubMed Web of Science ®Google Scholar
• Korzeniewski, C.; Callewaert, D.M. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 1983, 64, 313–320.
   PubMed Web of Science ®Google Scholar
• Frawley, R.; DeVito, M.; Walker, N.J.; Birnbaum, L.; White, K.; Smith, M.; Maaynor, T.; Recio, L.; Germolec, D. Relative potency for altered humoral immunity induced by polybrominated and polychlorinated dioxins/furans in female B6C3F1/N mice. Toxicol. Sci. 2014, 139(2), 488–500.
   PubMed Web of Science ®Google Scholar
• Flaveny, C.A.; Murray, I.A.; Chiaro, C.R.; Perdew, G.H. Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice. Mol. Pharmacol. 2009, 75, 1412–1420.
   PubMed Web of Science ®Google Scholar